Holen Sie sich die Stockscreener-App
12.06
3.25%
0.38
Schlusskurs vom Vortag:
$11.68
Offen:
$11.68
24-Stunden-Volumen:
365.70K
Relative Volume:
1.12
Marktkapitalisierung:
$442.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.03%
1M Leistung:
-22.29%
6M Leistung:
-51.15%
1J Leistung:
+0.00%
1-Tages-Spanne:
$11.61
$12.27
1-Wochen-Bereich:
$11.35
$12.60
52-Wochen-Spanne:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
Firmenname
Ceribell Inc
Sektor
Branche
Telefon
(800) 436-0826
Adresse
360 N. PASTORIA AVENUE, SUNNYVALE
Vergleichen Sie CBLL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
12.06 | 446.57M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-24 | Eingeleitet | BTIG Research | Buy |
| 2025-04-04 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2024-11-05 | Eingeleitet | BofA Securities | Buy |
| 2024-11-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-11-05 | Eingeleitet | JP Morgan | Overweight |
| 2024-11-05 | Eingeleitet | TD Cowen | Buy |
| 2024-11-05 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ceribell Inc Aktie (CBLL) Neueste Nachrichten
Custom Dashboard Highlights CeriBell Inc. Price MomentumWall Street Watch & Reliable Price Action Trade Plans - thegnnews.com
Sector Rotation Brings CeriBell Inc. Into FocusGap Up & Technical Pattern Recognition Alerts - newsimpact.co.kr
CeriBell Inc. Ranks High in Smart Money Tracker2025 Price Targets & Consistent Profit Alerts - classian.co.kr
Will CeriBell Inc. price bounce be sustainable2025 Dividend Review & Verified Entry Point Detection - Newser
Best data tools to analyze CeriBell Inc. stockEarnings Recap Report & Free High Return Stock Watch Alerts - Newser
Will CeriBell Inc. stock recover after recent dropMarket Performance Summary & AI Enhanced Trade Execution Alerts - Newser
Using RSI to spot recovery in CeriBell Inc.Market Sentiment Report & Weekly Top Performers Watchlists - Newser
CeriBell Inc. Stock Support and Resistance Levels You Should KnowOil Prices & Weekly Stock Performance Updates - Newser
What data driven models say about CeriBell Inc.’s futurePortfolio Return Report & Long-Term Safe Investment Ideas - Newser
Multi factor analysis applied to CeriBell Inc.Quarterly Portfolio Summary & Expert Curated Trade Setup Alerts - Newser
Is this a good reentry point in CeriBell Inc.2025 Performance Recap & Detailed Earnings Play Strategies - Newser
MACD Signals Flash Warning for CeriBell Inc. StockPortfolio Return Summary & AI Powered Buy/Sell Recommendations - sundaytimes.kr
Relief Rally in CeriBell Inc. Stock — Can It HoldQuarterly Market Summary & Community Supported Trade Ideas - beatles.ru
Applying Wyckoff theory to CeriBell Inc. stock2025 Stock Rankings & Smart Money Movement Tracker - Newser
Is CeriBell Inc. meeting your algorithmic filter criteriaQuarterly Profit Report & AI Optimized Trade Strategies - Newser
Tools to assess CeriBell Inc.’s risk profileOil Prices & Daily Momentum Trading Reports - Newser
J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT - MSN
What does recent volatility data suggest for CeriBell Inc.Market Performance Report & AI Powered Buy and Sell Recommendations - Newser
Ceribell reports Q2 EPS (38c), consensus (40c) - MSN
Ceribell alleges EEG patent infringement by Natus - BioWorld MedTech
Ceribell, Inc.: Strategic Expansion and Diversification Drive Positive Outlook - TipRanks
12 Best Medical Device Stocks to Buy According to Analysts - Insider Monkey
Intraday pattern recognizer results for CeriBell Inc.Entry Zone Watchlist With Momentum Focus - Newser
Research Analysts Set Expectations for CeriBell Q3 Earnings - Defense World
Ceribell, Inc. Reports Strong Q2 2025 Revenue Growth - TipRanks
CeriBell, Inc. (NASDAQ:CBLL) Second-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year - simplywall.st
Ceribell, Inc. Reports Strong Q2 Growth Amid Challenges - The Globe and Mail
CeriBell Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Institutional investors in CeriBell, Inc. (NASDAQ:CBLL) must be dismayed after prices dropped by 14% last week - simplywall.st
Ceribell raises FY25 revenue view to $85M-$88M from $83M-$87M - MSN
Ceribell, Inc. Faces Financial Uncertainty Amid Trade Policy Shifts and Tariff Challenges - TipRanks
CeriBell (CBLL) Q2 Revenue Jumps 38% - The Globe and Mail
Ceribell outlines $85M–$88M 2025 revenue target while expanding pediatric and neonate pilots - MSN
CeriBell Q2 2025 Earnings Call Transcript - MarketBeat
CeriBell's Q2 2025 Earnings: A Turnaround Play in a High-Stakes Neurodiagnostics Market - AInvest
Ceribell Reports Second Quarter 2025 Financial Results - The Manila Times
CeriBell 2025 Q2 Earnings Loss Narrows Despite Revenue Surge - AInvest
CeriBell Inc (CBLL): Assessing the Long-Term Value of a High-Growth, Pre-Profit Med-Tech Innovator - AInvest
CeriBell, Inc.'s Q2 2025 Earnings: Unpacking Contradictions on Margins, Market Expansion, and Growth Strategy - AInvest
Transcript : CeriBell, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: CeriBell Inc Q2 2025 shows revenue growth, stock dips By Investing.com - Investing.com South Africa
Earnings call transcript: CeriBell Inc Q2 2025 shows revenue growth, stock dips - Investing.com Canada
CeriBell Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Reversal Traders Monitor CeriBell Inc. for EntryCapital Doubling Tips - beatles.ru
How to build a custom watchlist for CeriBell Inc.Day Trading Setup Forecast with Trend Model - Newser
Published on: 2025-08-04 23:36:04 - Newser
Ceribell, Inc.: Positioned for Growth with Strong Revenue Projections and Market Expansion Opportunities - TipRanks
How strong is CeriBell Inc. company’s balance sheetCapitalize on emerging industry trends - Jammu Links News
CeriBell Inc. Stock Analysis and ForecastAchieve superior returns through strategic trading - Jammu Links News
What drives CeriBell Inc. stock priceBreakneck growth rates - Jammu Links News
Finanzdaten der Ceribell Inc-Aktie (CBLL)
Es liegen keine Finanzdaten für Ceribell Inc (CBLL) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Ceribell Inc-Aktie (CBLL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Jul 07 '25 |
Option Exercise |
2.24 |
25,000 |
56,000 |
801,222 |
| Chao Xingjuan | President and CEO |
Jul 07 '25 |
Sale |
17.70 |
25,000 |
442,500 |
776,022 |
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):